Journal of Preventive Medicine And Care

Journal of Preventive Medicine And Care

Journal of Preventive Medicine And Care – Submit Paper

Open Access & Peer-Reviewed

Submit Manuscript

Submit Your Epidemiology Research to JPMC

Join Leading Population Health Researchers Publishing Rigorous, Impactful Studies

Start Your Submission Now

Secure Online Submission Portal

Complete your submission in 15 minutes with our streamlined, author-friendly platform

💾

Auto-Save Technology

Never lose your progress. Our system automatically saves your work every 30 seconds.

🔒

Secure & Encrypted

Bank-level encryption protects your research data and personal information.

📊

Real-Time Tracking

Monitor your manuscript status 24/7 from submission through publication.

📝

Guided Workflow

Step-by-step instructions ensure you provide all required information correctly.

Access Submission Portal https://oap.manuscriptzone.net

Why Submit Your Epidemiology Research to JPMC?

Expert Epidemiology Reviewers

Your manuscript will be evaluated by specialists in population health methods, disease surveillance, statistical modeling, and public health policy. Our reviewers understand the nuances of epidemiological research and provide constructive, field-specific feedback that strengthens your work.

Fast, Transparent Review Process

Receive your first decision within 21 days. We respect your time and understand the urgency of publishing timely epidemiological findings, especially for outbreak investigations and emerging health threats. Track every stage of review in real-time through our portal.

Global Reach Through Indexing

Your research will be indexed in Google Scholar, ensuring maximum visibility among epidemiologists, public health practitioners, policymakers, and healthcare professionals worldwide. Open access guarantees unrestricted readership.

Rigorous Yet Supportive

We maintain high scientific standards while supporting authors through the publication process. Our editorial team provides clear guidance on revisions, and we offer pre-submission inquiries for complex studies or novel methodologies.

Author-Friendly Policies

Retain copyright of your work. No restrictions on data sharing or preprint posting. APC waivers available for authors from low-income countries and unfunded research. We believe financial barriers should never prevent important epidemiological findings from reaching the public health community.

Ethical & Transparent

We adhere to COPE guidelines and maintain transparent peer review processes. Competing interests are clearly disclosed. Our commitment to research integrity ensures your work is evaluated fairly and published with the highest ethical standards.

Epidemiology Article Types We Publish

JPMC welcomes diverse epidemiological research that advances population health knowledge and informs public health practice. Each manuscript type undergoes rigorous peer review by experts in your specific research area.

Population-Based Cohort Studies

Longitudinal studies examining disease incidence, risk factors, and health outcomes in defined populations. Include detailed methodology on cohort selection, follow-up procedures, exposure assessment, and statistical analysis plans.

Systematic Reviews & Meta-Analyses

Comprehensive evidence syntheses following PRISMA guidelines. Must include protocol registration, systematic search strategies, quality assessment, and quantitative synthesis where appropriate. Ideal for summarizing epidemiological evidence on disease etiology or intervention effectiveness.

Outbreak Investigations & Surveillance Reports

Rapid reporting of disease outbreaks, cluster investigations, and surveillance system findings. Fast-tracked review for timely dissemination of critical public health information. Include case definitions, epidemiological curves, attack rates, and control measures implemented.

Epidemiological Methods & Statistical Innovations

Novel methodological approaches for disease modeling, causal inference, bias correction, or data collection. Include simulation studies, validation analyses, and practical guidance for implementation. Code and data sharing strongly encouraged.

Health Policy & Systems Research

Evaluations of health policies, interventions, or healthcare delivery systems using epidemiological methods. Include quasi-experimental designs, interrupted time series, difference-in-differences analyses, or natural experiments examining population health impacts.

Case-Control & Cross-Sectional Studies

Studies examining disease associations, prevalence estimates, or risk factor distributions. Clearly describe case and control selection, matching procedures, exposure assessment methods, and statistical approaches for confounding control.

Pre-Submission Checklist

Ensure your manuscript is complete before submission to avoid delays in the review process. Our portal will guide you through each requirement, but preparing these elements in advance will streamline your submission experience.

  • Manuscript File: Complete manuscript in Word (.doc/.docx) or LaTeX format, including title page, abstract (250 words max), keywords (5-8 terms), introduction, methods, results, discussion, and references. Follow epidemiology reporting guidelines (STROBE, CONSORT, PRISMA) as appropriate.
  • Figures & Tables: High-resolution figures (TIFF or EPS format, 300 DPI minimum) with descriptive captions. Tables in editable format (Word or Excel). Number all figures and tables consecutively and cite in text. Ensure epidemiological data visualizations (forest plots, survival curves, epidemic curves) are clear and publication-ready.
  • Ethics Documentation: IRB/Ethics committee approval letter or exemption certificate. Include protocol number and approval date. For human subjects research, confirm informed consent procedures. For secondary data analysis, document data access permissions.
  • Author Information: Complete names, affiliations, ORCID IDs, and email addresses for all authors. Designate corresponding author. Confirm all listed authors meet ICMJE authorship criteria and have approved the final manuscript version.
  • Competing Interests Declaration: Disclose all financial and non-financial competing interests for each author. Include funding sources, employment relationships, consultancies, stock ownership, and any other potential conflicts. If none exist, state "The authors declare no competing interests."
  • Data Availability Statement: Describe how readers can access underlying data. Options include public repository deposition (preferred), availability upon request, or explanation if data cannot be shared due to privacy/ethical restrictions. Include dataset DOIs when available.
  • Funding Information: List all funding sources supporting the research, including grant numbers. Acknowledge funding agencies' role (or lack thereof) in study design, data collection, analysis, and manuscript preparation.
  • Cover Letter: Address to the Editor-in-Chief, briefly summarize your study's significance to population health, explain why JPMC is the ideal venue, suggest potential reviewers (optional), and disclose any prior presentation or preprint posting of the work.

Peer Review Timeline: What to Expect

Transparency is core to our process. Here's exactly what happens after you click "Submit" and realistic timelines for each stage. Track your manuscript's progress in real-time through the submission portal.

1

Initial Screening

Our editorial team reviews your submission for completeness, scope fit, and adherence to guidelines. We run a plagiarism check using iThenticate (similarity index must be below 30%). Manuscripts are screened for ethical compliance and scientific rigor.

3 days
2

Editor Assignment

An Associate Editor with expertise in your specific epidemiological research area is assigned. They review the manuscript in detail and select 2-3 qualified peer reviewers from our database of epidemiologists, biostatisticians, and public health experts.

5 days
3

Peer Review

Reviewers evaluate your manuscript's methodology, statistical analysis, interpretation, and contribution to epidemiological knowledge. They assess study design appropriateness, potential biases, generalizability, and public health implications. Reviewers provide detailed, constructive feedback.

21 days
4

Editorial Decision

The Associate Editor synthesizes reviewer comments and makes a recommendation: Accept, Minor Revisions, Major Revisions, or Reject. You receive the decision letter with detailed reviewer feedback and specific revision requests. Average time from submission to first decision: 28 days.

3 days after reviews
5

Revision & Resubmission

If revisions are requested, you have 60 days to submit a revised manuscript with a point-by-point response to reviewer comments. Clearly explain how you addressed each concern or provide scientific justification for not making suggested changes. Revised manuscripts are typically re-reviewed.

Author timeline: 60 days
6

Re-Review & Final Decision

Revised manuscripts are sent back to original reviewers to verify that concerns were adequately addressed. The Associate Editor makes a final decision based on reviewer assessments of the revision quality.

14 days
7

Production & Publication

Accepted manuscripts enter production for copyediting, typesetting, and final formatting. You'll review proofs before publication. Articles are published online immediately upon completion and assigned a DOI for citation.

10 days

Total Timeline: Approximately 60 days from submission to publication (for manuscripts accepted without major revisions)

Trusted by the Epidemiology Community

21 Days Average Review Time
35% Acceptance Rate
100% Open Access
98% Author Satisfaction

Submission Guidelines Summary

Manuscript Formatting

  • File Format: Microsoft Word (.doc/.docx) or LaTeX (.tex with PDF)
  • Font: Times New Roman, 12pt, double-spaced throughout
  • Margins: 1 inch (2.54 cm) on all sides
  • Line Numbering: Continuous line numbers for easy reviewer reference
  • Page Numbers: Bottom center, starting from title page
  • References: Vancouver style (numbered citations in order of appearance)

Reporting Guidelines

Follow appropriate reporting guidelines for your study design:

  • STROBE: Observational studies (cohort, case-control, cross-sectional)
  • CONSORT: Randomized controlled trials
  • PRISMA: Systematic reviews and meta-analyses
  • RECORD: Observational studies using routinely collected health data
  • GATHER: Global health estimates
  • CHEERS: Health economic evaluations

Statistical Reporting

  • Report effect estimates with 95% confidence intervals
  • Specify all statistical tests used and justify their selection
  • Report exact p-values (not just "p < 0.05")
  • Describe handling of missing data and sensitivity analyses
  • For multivariable models, justify variable selection and report model diagnostics
  • Include sample size calculations and power analyses where appropriate

Data Sharing

JPMC strongly encourages data sharing to promote reproducibility and transparency in epidemiological research. Options include:

  • Public Repository: Deposit de-identified data in repositories like Dryad, Figshare, or Zenodo
  • Restricted Access: For sensitive health data, describe procedures for requesting access
  • Code Sharing: Share statistical analysis code (R, Stata, SAS, Python) via GitHub or OSF
  • Exemptions: If data cannot be shared due to ethical/legal restrictions, provide detailed explanation

Need Assistance?

Technical Support: For portal access issues, file upload problems, or system errors, contact our technical team at [email protected]

Pre-Submission Inquiries: Unsure if your manuscript fits JPMC's scope? Have questions about article types or formatting? Email the editorial office at [email protected] with a brief abstract and your questions.

Ready to Submit Your Epidemiology Research?

Join thousands of researchers who trust JPMC to publish their population health studies. Our expert reviewers, transparent process, and global reach ensure your work makes the impact it deserves.

Begin Your Submission

Complete your submission in 15 minutes • Track status in real-time • First decision in 21 days